Latest Innovation News

Pointerra Limited reported a 30% increase in customer receipts to A$2.6 million and positive operating cashflows in Q2 FY26, driven by major contracts including a US$2 million DOE grant with Georgia Power. The company’s digital twin SaaS platform continues to expand across key sectors, positioning it for sustained growth.

Telix Pharmaceuticals has met its upgraded FY 2025 revenue guidance with US$804 million, driven by strong growth in its Precision Medicine segment and the successful US launch of Gozellix. The company also advanced multiple clinical trials and announced a strategic collaboration with Varian to combine radiopharmaceuticals with radiation therapy.

FBR Limited has secured a binding conditional purchase order worth AUD 990,000 from a leading US heavy equipment dealer for its Mantis welding robot, marking a significant milestone during its prototyping phase.

Atomo Diagnostics has locked in exclusive global rights to a novel liver function test that rapidly detects liver injury, expanding its footprint in point-of-care diagnostics. The test, delivered on Atomo’s Pascal platform, targets drug-induced liver injury and chronic liver conditions with significant commercial potential.

29Metals Limited has announced a fully underwritten $150 million entitlement offer to bolster liquidity, address operational disruptions at Golden Grove, and accelerate development projects including the Gossan Valley and Capricorn Copper restart.

Lithium Universe has launched the engineering phase for a modular photovoltaic panel recycling plant that integrates cutting-edge technologies to recover high-purity silver, responding to soaring silver prices and rising demand from electric vehicles.

29Metals reported a strong December quarter with increased copper and zinc production at Golden Grove, cost efficiencies, and steady progress on key projects, while Capricorn Copper remains suspended pending regulatory approvals.

Litchfield Minerals has launched an Induced Polarisation survey to uncover concealed extensions of the Oonagalabi Formation, aiming to expand its mineral footprint southward and along key magnetic structures.

HUB24 has reported record net inflows of $5.6 billion in Q2 FY26, pushing total funds under administration to $152.3 billion and expanding its market share to 9.3%. The company also unveiled a new lifetime retirement solution and an AI-driven adviser ecosystem.

Vinyl Group Ltd has reported a landmark quarter with record cash receipts up 80% quarter-on-quarter and its first operating cash flow positive result, signalling a turning point for the music and culture company.

Telix Pharmaceuticals has achieved a key milestone with China’s NMPA accepting its New Drug Application for Illuccix, a prostate cancer imaging agent backed by strong Phase 3 data. This paves the way for Telix to enter a rapidly growing Chinese market alongside its global approvals.

Genetic Signatures reported a $3.3 million quarterly revenue with growing international sales and a robust cash position, while preparing for a leadership change.